About three-fourths of eye surgeons worldwide are estimated to use femtosecond lasers for various ophthalmic surgeries, says the 2016 ASCRS Clinical Survey. Ophthalmic femtosecond lasers provide comparatively less inflammation and less trauma to the tissues and results in early recovery. The increasing cases of vision impairment worldwide are promoting the growth of the global ophthalmic femtosecond lasers market predicts Fortune Business Insights in their new report.
According to the report, titled, “Ophthalmic Femtosecond Lasers Market Size, Share and Global Trend By Product (Equipment, Consumables and accessories), By Application (Refractive Surgery, Cataract Surgery, Keratoplasty, Pocket Creation, Intracorneal Rings, Incisions & Flap Cuts), By Type of Cells (Hospitals, Speciality Clinics, Ambulatory Surgical Centers, Eye Institutes) and Geography Forecast till 2026”, the cataract surgery segment is currently dominating the market and anticipated to continue dominant in the forecast period as well. This is owing to the increasing prevalence of diabetes and the rising number of cataract surgeries worldwide. The American Academy of Ophthalmology projects about 50 million people to be affected by cataract in the U.S. by the end of 2050. This is likely to boost the ophthalmic femtosecond lasers market in the near future.
Browse Complete Report:
FDA Approvals for Femtosecond Lasers to Bode Well for Market
Some of the companies operating in the global ophthalmic femtosecond lasers market include:
- Menlo Systems
- Johnson & Johnson Surgical Vision, Inc.
- Bausch & Lomb Incorporated
- IMRA America, Inc.
- LENSAR Inc.
- Ziemer Ophthalmic Systems
- Carl Zeiss Meditec AG
- Novartis AG (Alcon)
The report provides an in-depth analysis of the global ophthalmic femtosecond lasers market with a major focus on growth drivers and restraints and interesting insights to the market that will help vendors chalk out better strategies for future market revenue generation. All information gathered in this report are from both primary and secondary sources and provides a comprehensive market overview, covering the most significant trends prevalent in the market.
Technological Advancement in Femtosecond Lasers to Help Market Generate Attractive Revenue
The increasing prevalence of eye diseases is a major factor promoting the growth of the global ophthalmic femtosecond lasers market. The introduction of various techniques to detect various complexities of eye disorders and advancement in femtosecond lasers will also help the market witness better growth opportunities in the future. For instance, the launch of LanSx, an ophthalmic femtosecond laser in 2018 by a considerable player in the eye care solutions and Alcon, a division of Novartis AG will be used for treating intracorneal pockets and rings for presbyopia-correcting inlays. Such innovations are likely to bode well for the global market in the long run.
Get Sample PDF:
On the flipside, rise in complications such as the prominent position of phacoemulsification, capsular block syndrome, and pupillary constriction for cataract surgery may cause hindrance to the market in the forecast period.
Increasing Prevalence of Diabetes, followed by Eye Disorders to Help the Asia Pacific Generate Higher Revenue
The increasing number of patients undergoing cataract surgery in the developed nations of Canada and the U.S. are likely to help North America generate significant growth rate in future. In addition, the adoption of technological advancement in femtosecond lasers is also attracting more revenue to the regional market as more people are opting for this treatment.
On the other side, Asia Pacific ophthalmic femtosecond lasers market will witness a progressive growth rate on account of the rising prevalence of diabetes, followed by an increasing number of eye problems. In addition, surging number of ENT clinics and speciality centers is prognosticated to create lucrative growth opportunities for the market in the forecast duration
Some of the recent development made by companies include:
February’2018 – One of the leading players in femtosecond laser technology, LENSAR Inc., acquired the business unit of Precision Eye Services (PES) Inc.
April’2018– The FDA provided clearance to LENSAR Inc. for their laser system with Streamline IV, for including the creation of corneal pockets and flaps.
Speak to Analyst:
KEY QUESTIONS ANSWERED:
What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Why Choose Fortune Business Insights?
View Related Reports: